Seasonal Tailwind — august med 9.1% (mag 2/3) · posClose 70.00% (rel 2/3) · n10 ×0.75 = 6
Founder-Led — founder/CEO led
About Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, engages in the development of product candidates that precisely target proteins that are critical to immune cell maturation and function in the United States. The company's lead product candidate is soquelitinib (CPI-818), a selective covalent inhibitor of interleukin 2 inducible T cell kinase (ITK), which is in a multi-center Phase 1b/2 clinical trial for the treatment of … Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: March 23, 2016
Headquarters: 901 Gateway Boulevard, South San Francisco, CA, United States, 94080
Founder-Led: Yes — Richard Miller (Co-Founder, President, CEO & Chairman of the Board)
Key Metrics
Current Price
$15.67
Market Cap
$1.36B
Float
72.8M
Shares Outstanding
84.1M
vs. Analyst Target
+112.7% to analyst PT
Dividend Rate
None
Analyst Target Price
$33.33 (6 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
N/A
-$4.8M
-$632,000
-$43.1M
2021
N/A
-$43.2M
-$460,000
-$42.8M
2022
N/A
-$41.3M
-$367,000
-$40.9M
2023
N/A
-$27.0M
-$151,000
-$26.9M
2024
N/A
-$62.3M
-$85,000
-$62.2M
2025
N/A
-$15.3M
-$105,000
-$15.2M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Jun 2025
N/A
-$8.0M
Sep 2025
N/A
-$10.2M
Dec 2025
N/A
-$12.3M
Mar 2026
N/A
-$13.7M
Ownership & Float
Insider Ownership
3.5%
Institutional Ownership
85.5%
Short Float
24.6%
% of All Funds Holding
1.80%
Number of Funds Holding
148
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$13.22
Near-term / short-term trend
Weekly
40-Week SMA
$12.66
Medium-term trend
Weekly
80-Week SMA
$8.63
Cyclical trend (business cycle)
Weekly
200-Week SMA
$4.93
Secular trend (multi-year)
Monthly
10-Month SMA
$13.67
Near-term monthly trend
Monthly
20-Month SMA
$9.16
Medium-term monthly trend
Monthly
40-Month SMA
$6.04
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$7.80
support
4.50x
5 months ago
$2.80
support
1.97x
22 months ago
$1.60
support
1.54x
25 months ago
Historical Earnings Reactions (41 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
0.95%
0.47%
56.10%
25.97%
-10.91%
1 Day
0.39%
-0.22%
46.34%
32.24%
-14.76%
1 Week
5.72%
3.19%
51.22%
82.31%
-33.24%
2 Weeks
6.25%
3.77%
58.54%
136.92%
-36.30%
1 Month
6.14%
-3.49%
45.00%
175.38%
-42.14%
Next earnings: August 6, 2026 (25 days away)
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
14.9%
60.0%
10
Feb
-6.1%
30.0%
10
Mar
-2.6%
30.0%
10
Apr
-6.4%
45.5%
11
May
25.0%
63.6%
11
Jun
-3.8%
36.4%
11
Jul
5.4%
50.0%
10
Aug
14.7%
70.0%
10
Sep
10.6%
50.0%
10
Oct
1.8%
40.0%
10
Nov
0.4%
60.0%
10
Dec
-6.6%
20.0%
10
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
-0.15%
42.9%
483
Tuesday
0.34%
45.1%
532
Wednesday
0.32%
47.3%
529
Thursday
-0.09%
47.2%
521
Friday
0.53%
46.8%
519
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 85.5%
Insider Transactions — Smart Summary
Total insider ownership: 3.5%
Founder-led management: Richard Miller (Co-Founder, President, CEO & Chairman of the Board)
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Corvus Pharmaceuticals Inc
(CRVS) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.